APA (7th ed.) Citation

NC, B., MC, B., SL, H., T, M., OJ, M., ED, L., . . . KJ, R. (2025). Elexacaftor/tezacaftor/ivacaftor prescription in lung transplant recipients with cystic fibrosis in the US. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 24(5), 929. https://doi.org/10.1016/j.jcf.2025.06.005

Chicago Style (17th ed.) Citation

NC, Burdis, et al. "Elexacaftor/tezacaftor/ivacaftor Prescription in Lung Transplant Recipients with Cystic Fibrosis in the US." Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society 24, no. 5 (2025): 929. https://doi.org/10.1016/j.jcf.2025.06.005.

MLA (9th ed.) Citation

NC, Burdis, et al. "Elexacaftor/tezacaftor/ivacaftor Prescription in Lung Transplant Recipients with Cystic Fibrosis in the US." Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society, vol. 24, no. 5, 2025, p. 929, https://doi.org/10.1016/j.jcf.2025.06.005.